# Safety and Efficacy of Lyophilized Faecal Microbiota Transplantation Via Capsules in Treatment of Irritable Bowel Syndrome

> **NCT07481422** · PHASE1,PHASE2 · RECRUITING · sponsor: **University of Rijeka** · enrollment: 70 (estimated)

## Conditions studied

- Irritable Bowel Syndrome (IBS)

## Interventions

- **OTHER:** FMT capsule
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07481422
- **Lead sponsor:** University of Rijeka
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-15
- **Primary completion:** 2027-03-15
- **Final completion:** 2027-12-15
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2026-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07481422

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07481422, "Safety and Efficacy of Lyophilized Faecal Microbiota Transplantation Via Capsules in Treatment of Irritable Bowel Syndrome". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT07481422. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*